The Health Care M&A Monthly: CSL Buys Talecris Biotherapeutics–
Pays $3.1 Billion To Bolster Plasma Derivatives Business Email this article to a friend Email Editor The largest deal to be announced in August reflects several current trends in the health care M&A market. It shows us how the biotech industry is broadening...The Health Care M&A Monthly: Willkommen, Bienvenue, Welcome–
Foreign Buyers Dominate Recent M&A Market Email this article to a friend Email Editor A few years back, American tourists streamed across the border into Canada. The robust American dollar allowed them to shop and spend at what would have been considered...The Health Care M&A Monthly: The Biotech Boom Continues–
Sixteen Deals Announced Worth $50.0 Billion Email this article to a friend Email Editor For the third time this year, the Biotechnology sector leads the pack in merger and acquisition activity. With 16 deals announced worth a provisional total of $50.0 billion,...Medical Devices Get Most Funding in Slow Stretch for VC: Mid-Year Results
FOR IMMEDIATE RELEASE Stephen M. Monroe, Partner Gretchen S. Swanson, Associate Editor 800-248-1668 203-846-6800 Fax: 203-846-8300 pressreleases@levinassociates.com Norwalk, CT – July 14, 2008 – 2008-Mid-year results reveal that the last time the health...The Health Care M&A Monthly: What They’re Paying For Medical Device Companies
During the recent past, the Medi-cal Device sector has proved it self to be one of the stalwarts of the health care M&A market. In the past three quarters, for example, this sector has contributed the largest number of deals to the total number announced in each...Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
